Yazan J Meqbil

Engineering Quick- and Long-acting Naloxone Delivery Systems for Treating Opioid Overdose

Kinam Park, Farrokh Sharifi, A. Otte, 2021, Pharmaceutical Research.

Modulating β-arrestin 2 recruitment at the δ- and μ-opioid receptors using peptidomimetic ligands.

David K. Johnson, Ryan A. Altman, Yazan J Meqbil, 2021, RSC medicinal chemistry.

ClickArr: a novel, high-throughput assay for evaluating β-arrestin isoform recruitment

Yazan J Meqbil, R. V. van Rijn, Alexander R. French, 2023, Frontiers in pharmacology.

Opportunities and Challenges for In Silico Drug Discovery at Delta Opioid Receptors

Yazan J Meqbil, R. Rijn, Yazan J. Meqbil, 2022, Pharmaceuticals.

Modified Akuamma Alkaloids with Increased Potency at the Mu-opioid Receptor.

Z. Wang, Andrew P Riley, Andrew P. Riley, 2023, Journal of medicinal chemistry.

Receptor-Selective Agonist Chemotype

Yazan J Meqbil, Robert J. Cassell, R. Rijn, 2022 .

Identification of a Novel Delta Opioid Receptor Agonist Chemotype with Potential Negative Allosteric Modulator Capabilities

Yazan J Meqbil, Anna M. Gutridge, R. V. van Rijn, 2021, Molecules.